RA Capital Management »

Atrium Therapeutics shares owned by RA Capital Management

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by RA Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $12M 864k 13.37

More positions owned by RA Capital Management

Ascendis Pharma A/s - Sponsored Adr (ASND)
Vaxcyte Common Stock (PCVX)
Rhythm Pharmaceuticals Common Stock (RYTM)
Tyra Biosciences Common Stock (TYRA)
Sionna Therapeutics Common Stock (SION)
Edgewise Therapeutics Common Stock (EWTX)
Newamsterdam Pharma Co Nv Common Stock (NAMS)
Nuvalent Inc-a Common Stock (NUVL)
Dianthus Therapeutics Common Stock (DNTH)
Mineralys Therapeutics Common Stock (MLYS)
Spyglass Pharma Common Stock
Wave Life Sciences Common Stock (WVE)
Septerna Common Stock (SEPN)
Disc Medicine Common Stock (IRON)
Janux Therapeutics Common Stock (JANX)

View all positions for RA Capital Management

Top funds holding Atrium Therapeutics

BlackRock
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Weiss Asset Management LP[1
Cantor Fitzgerald, L. P.
Balyasny Asset Management
Squarepoint Ops
Fort Hoosac Management

View all funds holding Atrium Therapeutics